Address: Ramallo 1851 C.P. 1429, Buenos Aires,Argentina
Tel: +54 11 4703 7000
Web: http://www.ar.novartis.com/
Formed in 1996 from two historic pharmaceutical companies, Sandoz and CIBA Vision, Novartis is a relatively young player with a lot of history. These two companies are now subsidiaries of Novartis, however, Novartis Pharmaceuticals Argentina is a separate company, which is one of the small number of multinational pharmaceutical companies to have consistently succeeded in the market, particularly in the therapeutic areas of cardiology, transplants, ophthalmology and respiratory solutions.
Last year, Novartis invested $10 million in R & D in Argentina, showing their commitment to the country. This is also shown through their heavy involvement in community education and medication programmes, helping the worst-off in Argentina get access to free medicines. Novartis has also been voted one of the best places to work in Argentina.
Neuroscience, Opthamology, Oncology, Respitory System
When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a…
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies…
Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the…
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
See our Cookie Privacy Policy Here
